Skip to content

Duncan Jason

Reporting owner on Forms 3, 4 and 5, CIK 1741553.

Duncan Jason reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-13.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ENGN · enGene Therapeutics Inc.CIK 1980845officer (Chief Legal & Admin Officer)22026-11-13

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ENGN · enGene Therapeutics Inc.Stock Option (Right to Buy), derivative2026-11-13A granted+500,000$0500,000Form 4
ENGN · enGene Therapeutics Inc.No securities beneficially held, holding 0Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001552781-26-000553 enGene Therapeutics Inc.2026-11-13
Form 3 0001552781-26-000552 enGene Therapeutics Inc.2026-11-13